Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal

Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)

Published:2019-04-02 Issue:6 Volume:10 Page:1527-1536
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Kawaguchi Yuji¹^ORCID,Sawa Jun¹,Hamai Chie¹,Nishimura Yuri¹,Kumeda Yasuro¹

Affiliation:

1. Department of Internal Medicine Minamiosaka Hospital Osaka Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13038

Reference45 articles.

1. Microvascular and Macrovascular Complications of Diabetes

2. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

3. Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial

4. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia;Veneman T;Diabetes,1993

5. The Burden of Treatment Failure in Type 2 Diabetes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure;Clinical Pharmacology in Drug Development;2024-03-21

2. Efficacy of Insulin Degludec/Insulin Aspart (IDegAsp) vs. Insulin Glargine (IGlarU300) in Insulin-Naïve Patients with Type 2 Diabetes: A Retrospective Study;Clinical Diabetology;2024-03-01

3. Use of wearables for monitoring cardiometabolic health: A systematic review;International Journal of Medical Informatics;2023-11

4. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

5. Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials;Endocrine Journal;2022